Takeda Collaborates with Evotec on RNA Targeting Drug Development

 Takeda Collaborates with Evotec on RNA Targeting Drug Development

Takeda Collaborates with Evotec on RNA Targeting Drug Development

Shots:

  • Evotec to receive research funding and will be eligible for $160M/program as discovery, pre/ clinical, a commercial milestone along with royalties on sales of product emerges from the collaboration
  • The collaboration will utilize Evotec’s RNA targeting platform to identify RNA sequences to target with small-molecule ligands aligned that can be developed into the first-in-class therapeutics
  • The companies will jointly identify & develop small molecules targeting a range of RNA targets aligned with Takeda’s research and development areas

Click here ­to­ read full press release/ article | Ref: Evotec | Image: Wikipedia

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post